Erythema multiforme - 多形紅斑
https://en.wikipedia.org/wiki/Erythema_multiforme
☆ AI Dermatology — Free Service德國 Stiftung Warentest 2022 年的結果顯示,消費者對 ModelDerm 的滿意度僅略低於付費遠距醫療諮詢。 relevance score : -100.0%
References
Recent Updates in the Treatment of Erythema Multiforme 34577844 NIH
Erythema multiforme (EM) 是一種由免疫反應引起,於皮膚與黏膜上出現特徵性靶狀斑點的疾病。雖然多數情況是因病毒感染(尤其是單純皰疹病毒 (HSV))或特定藥物觸發,但仍有不少病例原因不明。治療急性 EM 的重點是使用含類固醇或抗組織胺的外用藥膏以緩解症狀。針對每位患者量身訂做的復發性 EM 治療方案最為有效。首選的治療包括口服與局部用藥,常見藥物有皮質類固醇與抗病毒藥物。局部治療可使用強效類固醇乳膏及針對受累黏膜的溶液。對於抗病毒藥物無效的患者,第二線選擇包括免疫抑制劑、抗生素、驅蟲藥及抗瘧藥。
Erythema multiforme (EM) is an immune-mediated condition that classically presents with discrete targetoid lesions and can involve both mucosal and cutaneous sites. While EM is typically preceded by viral infections, most notably herpes simplex virus (HSV), and certain medications, a large portion of cases are due to an unidentifiable cause. Treatment for acute EM is focused on relieving symptoms with topical steroids or antihistamines. Treatment for recurrent EM is most successful when tailored to individual patients. First line treatment for recurrent EM includes both systemic and topical therapies. Systemic therapies include corticosteroid therapy and antiviral prophylaxis. Topical therapies include high-potency corticosteroids, and antiseptic or anesthetic solutions for mucosal involvement. Second-line therapies for patients who do not respond to antiviral medications include immunosuppressive agents, antibiotics, anthelmintics, and antimalarials
Use of steroids for erythema multiforme in children 16353829 NIH
在許多情況下,輕度 erythema multiforme(多形紅斑)通常會在 2 至 4 週內自行消退。史蒂文斯-約翰遜症候群是一種影響黏膜的嚴重疾病,病程可持續長達 6 週。對於輕度病例,通常不建議使用類固醇。至於是否應將類固醇用於治療嚴重的多形紅斑,仍未確定,因為隨機研究尚未明確顯示哪些兒童能從此治療中受益。
In most cases, mild erythema multiforme is self-limited and resolves in 2 to 4 weeks. Stevens-Johnson syndrome is a serious disease that involves the mucous membranes and lasts up to 6 weeks. There is no indication for using steroids for the mild form. Use of steroids for erythema multiforme major is debatable because no randomized studies clearly indicate which children will benefit from this treatment.
Drug-induced Oral Erythema Multiforme: A Diagnostic Challenge 29363636 NIH
我們報告一例因 TMP/SMX 引發的口腔 erythema multiforme (EM) 病例,表現為典型的口腔及唇部潰瘍,無皮膚病變。此例強調了需將其與其他口腔潰瘍性疾病加以區分。患者接受對症治療及口服潑尼松龍片,停用 TMP/SMX 後病情逐漸好轉。
We report a case of oral erythema multiforme (EM) secondary to TMP/SMX that presented with oral and lip ulcerations typical of EM without any skin lesions and highlights the importance of distinguishing them from other ulcerative disorders involving oral cavity. The patient was treated symptomatically and given tablet prednisolone. The condition improved with stoppage of TMP/SMX therapy.
Erythema Multiforme: Recognition and Management. 31305041Erythema multiforme 是一種涉及皮膚、偶爾波及黏膜的免疫反應。它通常呈現為靶樣病變,可為單發、復發或持續存在。這些病變多對稱分布於四肢,尤其是外側表面。主要誘因包括單純皰疹病毒、肺炎黴漿菌等感染,以及某些藥物、免疫接種和自體免疫疾病。 Erythema multiforme 與蕁麻疹的區別在於病灶的持續時間;Erythema multiforme 的病灶至少維持 7 天,而蕁麻疹的病變通常在一天內消退。雖然兩者外觀相似,但必須將 Erythema multiforme 與更嚴重的史蒂文斯-約翰遜症候群(Stevens‑Johnson syndrome)區分開來,後者常表現為廣泛紅斑或紫斑,伴隨水皰。 Erythema multiforme 的治療包括使用局部類固醇或抗組織胺緩解症狀,同時處理根本原因。對於與單純皰疹病毒相關的復發病例,建議採取預防性抗病毒治療。若黏膜受累嚴重,可能需要住院接受靜脈輸液與電解質補充。
Erythema multiforme is a reaction involving the skin and sometimes the mucosa, triggered by the immune system. Typically, it manifests as target-like lesions, which may appear isolated, recur, or persist. These lesions usually symmetrically affect the extremities, particularly their outer surfaces. The main causes include infections like herpes simplex virus and Mycoplasma pneumoniae, as well as certain medications, immunizations, and autoimmune diseases. Distinguishing erythema multiforme from urticaria relies on the duration of lesions; erythema multiforme lesions remain fixed for at least seven days, while urticarial lesions often vanish within a day. Although similar, it's crucial to differentiate erythema multiforme from the more severe Stevens-Johnson syndrome, which typically presents widespread erythematous or purpuric macules with blisters. Managing erythema multiforme involves symptomatic relief with topical steroids or antihistamines and addressing the underlying cause. For recurrent cases associated with herpes simplex virus, prophylactic antiviral therapy is recommended. Severe mucosal involvement may necessitate hospitalization for intravenous fluids and electrolyte replacement.
病情範圍從輕微的自限性皮疹到危及生命的多形性紅斑(亦可累及黏膜)不等。黏膜受累或出現大皰是判斷嚴重程度的重要指標。
- Erythema multiforme minor:典型的目標樣或分佈於肢端的凸起、水腫性丘疹。輕度形式通常伴隨輕度搔癢(但搔癢有時會非常嚴重)、粉紅色斑點,呈對稱排列,從四肢開始。此類皮疹通常在 7–10 天內自行消退。
- Erythema multiforme major:典型的目標樣或凸起、水腫性丘疹,分佈於肢端,且累及一層或多層黏膜。表皮脫落的範圍不超過全身表面積的 10%。
○ 治療 – 非處方藥
若伴有發燒(體溫升高),建議儘速前往醫院就診。
應立即停用可疑藥物(例如抗生素、非類固醇抗發炎藥)。
口服抗組織胺藥(如西替利嗪、氯雷他定)以緩解癢感。
#Cetirizine [Zytec]
#LevoCetirizine [Xyzal]
#Loratadine [Claritin]